nextwave-pharmaceuticals

Nuelle

The company develops pharmaceutical treatments for central nervous system conditions, including depression and attention deficit hyperactivity disorder, for patients requiring specialised medical care.

nupathe-pharma

This company develops transdermal patches and biodegradable implants to deliver medication for central nervous system disorders like migraines and Parkinson's disease.

Corium

This biopharmaceutical company develops and commercialises central nervous system therapies and drug delivery systems for patients with neurological disorders.

NeuroRX

This company develops small molecule medicines for patients with central nervous system disorders, such as suicidal bipolar depression and post-traumatic stress disorder.

Arvelle Therapeutics

This biopharmaceutical company develops and commercialises antiepileptic medicines to treat patients suffering from central nervous system disorders.

Civitas Therapeutics

This biopharmaceutical company develops inhaled drug delivery technologies for patients with neurological disorders such as Parkinson's disease.

Collegium

This pharmaceutical company develops and commercialises prescription medicines for chronic pain and attention deficit hyperactivity disorder to help patients with serious medical conditions.

map-pharmaceuticals

This company develops inhaled therapies for neurological and respiratory conditions, such as migraines and asthma, for patients requiring systemic or targeted drug delivery.